SCHEMBL380345

SCHEMBL380345

Cc1ccc(C)c([Si]([O])(c2cc(C)ccc2C)c2cc(C)ccc2C)c1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.42
ALDH1A1 P00352 2/20 0.42
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2A6 P11509 2/20 0.38
HSD17B10 Q99714 2/20 0.38
TP53 P04637 1/20 0.37
GAA P10253 2/20 0.36
TAAR1 Q96RJ0 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
RAPGEF4 Q8WZA2 1/20 0.34
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.33
NQO2 P16083 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1992127 0.80 TDP1 (0.42) TDP1ALDH1A1MEN1KMT2ACYP1A2
SCHEMBL9463221 0.77 TDP1 (0.44) TDP1ALDH1A1MAOAMAOBCYP1A2
SCHEMBL7028012 0.75 TDP1 (0.42) TDP1ALDH1A1MAOAMAOBCYP1A2
SCHEMBL843553 0.75 TDP1 (0.42) TDP1ALDH1A1MAOAMAOBCYP1A2
SCHEMBL1686690 0.75 ALDH1A1 (0.42) TDP1ALDH1A1MEN1KMT2ACYP1A2
SCHEMBL1686686 0.75 TDP1 (0.48) TDP1ALDH1A1MEN1KMT2ACYP1A2
SCHEMBL842483 0.75 TDP1 (0.42) TDP1ALDH1A1MAOAMAOBCYP1A2
SCHEMBL16707371 0.75 TDP1 (0.42) TDP1ALDH1A1KMT2AMAOAMAOB
SCHEMBL1315699 0.75 TDP1 (0.42) TDP1ALDH1A1KMT2AMAOAMAOB
SCHEMBL2353433 0.73 TDP1 (0.41) TDP1ALDH1A1KMT2AMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1149086-B1 NOVEL PROCESS FOR THE REMOVAL OF A SILYLOXY PROTECTING GROUP FROM 4-SILYLOXY-TETRAHYDRO-PYRAN-2-ONES LEK TOVARNA FARMACEVTSKIH (SI) 2004-05-12 EP claimed
US-6509479-B1 To produce simvastatin LEK PHARMACEUTICALS D.D. (SI) 2003-01-21 US claimed
US-5650523-A REACTION IN SOLVENTS TO FORM HYDROXY GROUPS MERCK & CO., INC. (US) 1997-07-22 US claimed
EP-0444888-B1 Process for the desilylation of a 4-silyloxy-tetrahydro-pyran-2-one MERCK & CO INC (US) 1995-02-08 EP claimed
EP-0444888-A1 Process for the desilylation of a 4-silyloxy-tetrahydro-pyran-2-one MERCK & CO. INC. (US) 1991-09-04 EP claimed
US-20230405155-A1 NANOPARTICLE, PHOTOACOUSTIC CONTRAST AGENT, PHOTODYNAMIC THERAPY DRUG, AND PHOTOTHERMAL THERAPY DRUG SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-12-21 US disclosed
EP-4241846-A1 NANOPARTICLES, PHOTOACOUSTIC CONTRAST AGENT, PHOTODYNAMIC THERAPEUTIC AGENT, AND PHOTOTHERMAL THERAPEUTIC AGENT SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-09-13 EP disclosed
US-11312795-B2 Transition metal complex for use in or as a catalyst for olefin polymerization SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2022-04-26 US disclosed
CN-110799552-B Transition metal complexes for use in or as catalysts for olefin polymerization SABIC环球技术有限责任公司 2022-02-22 CN disclosed
EP-3442045-B1 ORGANIC PHOTOELECTRIC CONVERSION ELEMENT, AND SOLAR BATTERY MODULE AND SENSOR PROVIDED WITH SAME SUMITOMO CHEMICAL CO (JP) 2022-01-12 EP disclosed
US-11063219-B2 Organic photoelectric conversion element, and solar cell module and sensor provided with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2021-07-13 US disclosed
US-10854818-B2 Dendrimer compound and organic luminescent device employing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2020-12-01 US disclosed
EP-1238026-A2 PIGMENT CONCENTRATES AND METHODS FOR PRODUCTION THEREOF BASF AKTIENGESELLSCHAFT (DE) 2002-09-11 EP disclosed
US-20020016256-A1 Polymerization catalyst BASF AKTIENGESELLSCHAFT (DE) 2002-02-07 US disclosed
EP-1149086-A1 NOVEL PROCESS FOR THE REMOVAL OF A SILYLOXY PROTECTING GROUP FROM 4-SILYLOXY-TETRAHYDRO-PYRAN-2-ONES Lek Pharmaceutical and Chemical Co. D.D. (SI) 2001-10-31 EP disclosed
WO-2001044387-A2 PIGMENT CONCENTRATES AND METHODS FOR PRODUCTION THEREOF BASF AKTIENGESELLSCHAFT (DE) 2001-06-21 WO disclosed
WO-2000046217-A1 NOVEL PROCESS FOR THE REMOVAL OF A SILYLOXY PROTECTING GROUP FROM 4-SILYLOXY-TETRAHYDRO-PYRAN-2-ONES LEK PHARMACEUTICALS AND CHEMICAL COMPANY D.D. (SI) 2000-08-10 WO disclosed
US-5650523-A REACTION IN SOLVENTS TO FORM HYDROXY GROUPS MERCK & CO., INC. (US) 1997-07-22 US disclosed
EP-0444888-B1 Process for the desilylation of a 4-silyloxy-tetrahydro-pyran-2-one MERCK & CO INC (US) 1995-02-08 EP disclosed
EP-0444888-A1 Process for the desilylation of a 4-silyloxy-tetrahydro-pyran-2-one MERCK & CO. INC. (US) 1991-09-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230405155-A1 NANOPARTICLE, PHOTOACOUSTIC CONTRAST AGENT, PHOTODYNAMIC THERAPY DRUG, AND PHOTOTHERMAL THERAPY DRUG CRY2, RB1, NR2E3 TDP1 3946/4885ALDH1A1 1168/4885MEN1 1128/4885
US-10854818-B2 Dendrimer compound and organic luminescent device employing the same DCUN1D4, DCUN1D1, FLOT1 TDP1 683/4885ALDH1A1 1176/4885MEN1 1150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.